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ABSTRACT
PSF is considered to have multiple functions in
RNA processing, transcription and DNA repair by
mitotic recombination. In the present study, we
found that PSF is produced in spermatogonia,
spermatocytes and spermatids, suggesting that
PSF may also function in meiotic recombination.
We tested the effect of PSF on homologous pairing
by the meiosis-specific recombinase DMC1, and
found that human PSF robustly stimulated it.
PSF synergistically enhanced the formation of a
synaptic complex containing DMC1, ssDNA and
dsDNA during homologous pairing. The PSF-
mediated DMC1 stimulation may be promoted by
its DNA aggregation activity, which increases the
local concentrations of ssDNA and dsDNA for
homologous pairing by DMC1. These results sug-
gested that PSF may function as an activator for
the meiosis-specific recombinase DMC1 in higher
eukaryotes.
INTRODUCTION
Homologous recombination is an essential process
for meiotic cell division I (1,2). Dmc1 is a eukaryotic
homologs of the bacterial RecA recombinase, which
promotes a key step, homologous pairing, during homolo-
gous recombination. Dmc1-deﬁcient mice (3–5) and yeast
(6) are sterile due to defects in homologous recombin-
ation, indicating its essential function in meiotic
recombination. In mitosis, homologous recombination is
also required for the accurate repair of DNA
double-strand breaks (DSBs) (7–10). Since Dmc1 is
produced only in meiotic cells, another RecA homolog,
Rad51, is responsible for homologous pairing in mitotic
DSB repair through homologous recombination.
Human DMC1, yeast Dmc1 and rice DMC1A and
DMC1B actually promote homologous pairing in vitro
(11–16). In the homologous-pairing step, Dmc1 binds to
single-stranded DNA (ssDNA), and the Dmc1–ssDNA
complex then binds double-stranded DNA (dsDNA) to
form a ternary complex called the synaptic complex. In
this synaptic complex containing Dmc1, ssDNA and
dsDNA, the homologous sequences between ssDNA and
dsDNA are searched, and a heteroduplex is formed
between the incoming ssDNA and the complementary
strand of dsDNA. Previous biochemical studies revealed
that the human, mouse and yeast Hop2–Mnd1 complexes
(17–21), the yeast Swi5–Sfr1 complex (22), human
RAD54B (14,23,24) and RAD51AP1 (25) stimulate hom-
ologous pairing mediated by Dmc1. These proteins also
stimulate the Rad51-mediated homologous pairing
(17,18,20,22,26–28). Meiotic cells produce both Dmc1
and Rad51; however, the functional difference between
them has not been elucidated. Ancillary factors that
induce the distinct functions of Dmc1 and Rad51 may
exist for the proper regulation of these DNA
recombinase activities during meiotic processes.
Polypyrimidine tract binding protein associated splicing
factor (PSF, encoded by the SFPQ gene) is a multifunc-
tional protein involved in pre-mRNA processing (29–31),
transcription regulation (32–36) and DNA repair (37–39).
Previously, we reported that PSF directly interacts with
RAD51, and modulates the RAD51-mediated homolo-
gous pairing (40). PSF also reportedly interacts with
RAD51D, a RAD51 paralog, and is required for DNA
repair through homologous recombination between
sister chromatids (41). In addition, PSF was identiﬁed as
a protein that promotes homologous pairing between
ssDNA and dsDNA in HeLa cell nuclear extracts (42).
These ﬁndings strongly suggest that PSF may function
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binational DNA repair in mitotic cells. Interestingly,
PSF is produced in mouse Sertoli cells, which nourish
germ cells (43). These facts suggested that PSF may
function in meiotic recombination mediated by DMC1.
In the present study, we found that PSF is expressed in
testicular germ cells. Puriﬁed human PSF robustly
stimulated DMC1-mediated homologous pairing by
enhancing synaptic complex formation, probably
through its DNA aggregation activity. We also found
that PSF affected the DMC1-mediated and RAD51-
mediated recombination reactions differently in vitro.
Therefore, PSF may function to regulate the DMC1 and
RAD51 activities during meiotic processes.
MATERIALS AND METHODS
Preparation of testicular samples and immunoﬂuorescence
staining
For cryosections, adult mouse (3months old) testes
(Jcl:ICR) were decapsulated and ﬁxed with 2%
paraformaldehyde in phosphate buffered saline (PBS)
for 3h at 4 C. The ﬁxed tissues were incubated in 15%
sucrose in PBS, followed by 30% sucrose in PBS, then
cryo-embedded in optimal cutting temperature (OCT)
compound (Sakura Fine Tech, Tokyo, Japan). The
frozen blocks were cut into 10-mm thick sections
using a cryostat (Leica, Wetzlar, Germany). Structurally
preserved nuclei samples were prepared as described (44).
Since male mice initiate meiosis in a relatively synchron-
ous fashion at 2weeks after birth, we used testicular
samples from 2-week-old mice. Brieﬂy, testicular samples
were minced in MEM-alpha (GIBCO, Carlsbad, USA) to
release the germ cells, and then a drop of a single cell
suspension was placed on a slide glass and immediately
mixed with 3.7% formaldehyde and 100mM sucrose
in PBS (pH 7.4), to preserve the cellular structures.
After air drying at room temperature, the slides were
washed with water three times, air dried and stored at
 80 C until further use. The primary antibodies used
were an anti-PSF mouse monoclonal antibody (P2860,
Sigma-Aldrich, St Louis, MO, USA), and anti-DMC1
(sc-22768, Santa Cruz Biotechnology, Santa Cruz, USA),
anti-RAD51 (sc-8349, Santa Cruz Biotechnology),
anti-DAZL (ab34139, Abcam, Cambridge, UK), anti-
STRA8 (ab49602, Abcam) and anti-SYCP3 (45)
rabbit polyclonal antibodies. The secondary antibodies
were Alexa 488 conjugated anti-mouse and Alexa 568
conjugated anti-rabbit IgGs (Invitrogen, Carlsbad, CA,
USA). Nuclei were counterstained with 1mg/ml Hoechst
33258 dye (Sigma-Aldrich) or with an antifade solution
with DAPI (S36939, Invitrogen,). Images were obtained
with a ﬂuorescent microscope (BX61, Olympus, Tokyo,
Japan) mounted with a CCD camera (DP70, Olympus).
The immunoprecipitation assay
The mouse testis cells (adult mouse, 3months old) were
resuspended in lysis buffer, containing 20mM sodium
phosphate (pH 8.0), 60mM NaCl, 0.1mM EDTA,
0.05% Triton X-100, a protease inhibitor cocktail
(Nakarai Tesque, Kyoto, Japan) and 10% glycerol.
After a 15min incubation on ice, the cell lysate was
sonicated, and then centrifuged at 11000g for 5min
at 4 C. The supernatant was collected as a whole-cell
extract. The anti-PSF mouse monoclonal antibody
(12mg, P2860, Sigma-Aldrich) and the testis cell extract
(equivalent to  5 10
6 cells) were mixed and incubated
at 4 C for 3h. The sample was then mixed with 50mlo f
Dynabeads protein G (DYNAL, Carlsbad, CA, USA),
and was incubated at 4 C for 1h. After the incubation,
the immunoprecipitates were washed three times with 1ml
of the lysis buffer, and then eluted with SDS–PAGE
sample buffer. The immunoprecipitates were fractionated
by 12% SDS–PAGE, and were immunoblotted with an
anti-DMC1 rabbit polyclonal antibody and a horseradish
peroxidase conjugated anti-rabbit IgG antibody. Signals
were detected by using the Amershan ECL Prime Western
Blotting Detection Reagent (GE Healthcare Biosciences,
Uppsala, Sweden).
Protein puriﬁcation
Human PSF (40), DMC1 (13), RAD51 (46,47) and HOP2-
MND1 (18) were prepared by the methods described
previously. Brieﬂy, human PSF, DMC1, RAD51 and
HOP2-MND1 were expressed in Escherichia coli cells as
His6-tagged proteins, and the His6 tag was removed by
a thrombin protease treatment during the puriEcation
procedure.
The pull-down assay with Ni-NTA beads
Puriﬁed His6-tagged PSF (2.1mg) was mixed with
DMC1 (4mg) or RAD51 (4mg) in 60ml of binding
buffer, containing 12mM sodium phosphate (pH 7.5),
2mM HEPES–NaOH (pH 7.5), 66mM NaCl, 25mM
KCl, 0.16mM EDTA, 1.4mM 2-mercaptoethanol,
0.025% Triton X-100 and 6.8% glycerol, and Ni-NTA
agarose beads (1.5ml, 50% slurry) were then added.
After an incubation at room temperature for 1h, the
beads were washed twice with 300ml of wash buffer,
containing 20mM sodium phosphate (pH 7.5), 100mM
NaCl, 0.25mM EDTA, 2mM 2-mercaptoethanol and
10% glycerol. The proteins bound to the beads were
fractionated by 15% SDS–PAGE, and the bands were
visualized by Coomassie brilliant blue staining.
DNA substrates
In the D-loop formation assay, superhelical dsDNA
(pGsat4 DNA) was prepared by a method avoiding
alkaline treatment of the cells harboring the plasmid
DNA (48,49). For the ssDNA substrate used in the
D-loop formation assay, the following oligonucleotide
was purchased from Invitrogen, and puriﬁed by polyacryl-
amide gel electrophoresis: 50-mer, 50-ATT TCA TGC
TAG ACA GAA GAA TTC TCA GTA ACT TCT
TTG TGC TGT GTG TA-30. For the homologous-
pairing assay with oligonucleotides, the following
HPLC-puriﬁed DNA oligonucleotides were purchased
from Nihon Gene Research Laboratory: 63-mer, 50-TCC
TTT TGA TAA GAG GTC ATT TTT GCG GAT
GGC TTA GAG CTT AAT TGC TGA ATC TGG
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ATG ACC TCT TAT CAA AAG GA-30 and 50-TCC TTT
TGA TAA GAG GTC ATT TTT GCG GAT GG-30. For
the dsDNA capture assay, the following HPLC-puriﬁed
DNA oligonucleotides were purchased from Nihon Gene
Research Laboratory: 49-mer dsDNA, 50-GTC CCA
GGC CAT TAC AGA TCA ATC CTG AGC ATG
TTT ACC AAG CGC ATT G-30 and 50-CAA TGC
GCT TGG TAA ACA TGC TCA GGA TTG ATC
TGT AAT GGC CTG GGA C-30. For the ssDNA pro-
tection assay, the following HPLC-puriﬁed ssDNA oligo-
nucleotide was purchased from Nihon Gene Research
Laboratory: 100-mer, 50-CTT CGC GAC TCC AGT
GAT CGG ACG AGA ACC GGT GCA TTC ACC
CTG GTA TAG TCG ACG TCT CTT GCT TGA
TGA AAG TTA AGC TAT TTA AAG GGT CAG
GGA T-30. For the synaptic complex formation assay,
the following HPLC-puriﬁed ssDNA oligonucleotides
were purchased from Nihon Gene Research Laboratory:
70-mer homologous ssDNA, 50-CAT CAG AAA TAT
CCG AAA GTG TTA ACT TCT GCG TCA TGG
AAG CGA TAA AAC TCT GCA GGT TGG ATA
CGC C-30, 70-mer heterologous ssDNA, 50-GGT GCA
TTC ACC CTG GTA TAG TCG ACG TCT CTT
GCT TGA TGA AAG TTA AGC TAT TTA AAG
GGT CAG GGA T-30. Single-stranded fX174 viral (+)
strand DNA and double-stranded fX174 replicative form
I DNA were purchased from New England Biolabs.
The linear dsDNA was prepared from the fX174 replica-
tive form I DNA by PstI digestion. All of the DNA
concentrations are expressed in moles of nucleotides.
The D-loop formation assay
PSF and/or DMC1 were incubated with the
32P-labeled
50-mer oligonucleotide (1mM) at 37 C for 5min, in 9mlo f
reaction buffer, containing 20mM HEPES–NaOH (pH
7.5), 2.0mM HEPES–KOH (pH 7.5), 4mM Tris–HCl
(pH 8.0), 40mM NaCl, 50mM KCl, 0.045mM EDTA,
0.2mM 2-mercaptoethanol, 3% glycerol, 5mM MgCl2,
1.2mM DTT, 1mM ATP, 0.1mg/ml BSA, 20mM
creatine phosphate and 75mg/ml creatine kinase. The
reactions were then initiated by the addition of 1mlo f
pGsat4 superhelical dsDNA (30mM), and were continued
at 37 C for 10min. The reactions were stopped by the
addition of 0.2% SDS and 1.5mg/ml proteinase K
(Roche Applied Science, Basel, Switzerland), and were
further incubated at 37 C for 15min. After adding
6-fold loading dye, the deproteinized reaction products
were separated by 1% agarose gel electrophoresis in 1 
TAE buffer at 4V/cm for 2h. The gels were dried and
exposed to an imaging plate. The gel images were
visualized using an FLA-7000 imaging analyzer
(Fujiﬁlm, Tokyo, Japan).
The homologous-pairing assay with oligonucleotides
In this assay, a 63-mer ssDNA and a 32-mer dsDNA,
which were commonly employed in previous studies
(40,50–53), were used. DMC1 (4mM) and the indicated
amount of PSF were incubated with a 63-mer ssDNA
(15mM) at 37 C for 5min, in 9ml of reaction buffer,
containing 22mM HEPES–NaOH (pH 7.5), 4mM Tris–
HCl (pH 8.0), 40mM NaCl, 50mM KCl, 0.045mM
EDTA, 0.2mM 2-mercaptoethanol, 3% glycerol, 5mM
MgCl2, 1.2mM DTT, 1mM ATP, 0.1mg/ml BSA,
20mM creatine phosphate and 75mg/ml creatine kinase.
The reactions were initiated by the addition of 1ml of the
32-mer dsDNA (1.5mM), which shared sequence
homology with the 63-mer ssDNA. After a 30-min incu-
bation at 37 C, the reaction was stopped by the addition
of 0.2% SDS and 1.5mg/ml proteinase K, and was further
incubated at 37 C for 15min. After 6-fold loading dye was
added, the reaction mixtures were subjected to 15% poly-
acrylamide gel electrophoresis in 0.5  TBE buffer (45mM
Tris-base, 45mM boric acid and 1mM EDTA). The gels
were dried and exposed to an imaging plate. The gel
images were visualized using an FLA-7000 imaging
analyzer.
The ATPase assay
The ATPase activities of the proteins were analyzed by the
release of
32Pi from [g-
32P]ATP. The proteins were mixed
with a 49-mer single-stranded oligonucleotide (20mM),
in 10ml of reaction buffer, containing 22mM HEPES–
NaOH (pH 7.5), 2mM HEPES–KOH (pH 7.5), 6mM
Tris–HCl (pH 8.0), 75mM NaCl, 50mM KCl,
0.065mM EDTA, 5% glycerol, 0.4mM
2-mercaptoethanol, 1.3mM DTT, 50mM ATP, 5 nCi
[g-
32P]ATP, 5mM MgCl2 and 100mg/ml BSA. The
protein concentrations were 4mM for DMC1 and 1.2mM
for PSF. The reaction mixtures were incubated at 37 C. At
the indicated times, the reaction was stopped by the
addition of 0.5M EDTA, and the products were separated
by thin layer chromatography on polyethyleneimine-
cellulose in a 0.5M LiCl and 1M formic acid solution.
The dsDNA capture assay
DMC1 (4mM) and PSF (0.6mM) were incubated with a
50-biotinylated poly dT ssDNA (83-mer, 6mM) conjugated
to magnetic streptavidin beads at 37 C for 5min, in 9mlo f
reaction buffer, containing 22mM HEPES–NaOH (pH
7.5), 4mM Tris–HCl (pH 8.0), 40mM NaCl, 20mM
KCl, 0.045mM EDTA, 0.2mM 2-mercaptoethanol, 3%
glycerol, 5mM MgCl2, 1.2mM DTT, 1mM ATP,
0.1mg/ml BSA and 0.01% Nonidet P-40. The reactions
were initiated by the addition of 1mlo f
32P-labeled heter-
ologous dsDNA (49-mer, 6mM), and were continued at
37 C for 10min. The supernatants were transferred to
fresh tubes, and were treated with 0.4% SDS and
1.8mg/ml proteinase K at 37 C for 15min. The resulting
ssDNA beads were washed twice with 10ml of the reaction
buffer. The dsDNA captured by the ssDNA beads was
extracted by a treatment with 0.4% SDS and 1.8mg/ml
proteinase K at 37 C for 15min, followed by a phenol/
chloroform extraction and was analyzed by 10%
polyacrylamide gel electrophoresis in 0.5  TBE buffer.
The gels were dried and exposed to an imaging plate.
The gel images were visualized using an FLA-7000
imaging analyzer.
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The proteins were incubated with the
32P-labeled 100-mer
oligonucleotide (1mM) at 37 C for 5min, in 9mlo f
reaction buffer, containing 22mM HEPES–NaOH (pH
7.5), 2mM HEPES–KOH (pH 7.5), 4mM Tris–HCl (pH
8.0), 55mM NaCl, 50mM KCl, 0.055mM EDTA, 4%
glycerol, 0.4mM 2-mercaptoethanol, 1.2mM DTT,
1mM ATP, 5mM MgCl2 and 100mg/ml BSA. The reac-
tions were initiated by the addition of 5U of exonuclease I
(New England Biolabs, Ipswich, MA, USA), and were
continued at 37 C for 10min. The reaction was stopped
by the addition of 0.2% SDS and 1.5mg/ml proteinase K,
and was further incubated at 37 C for 15min. After 6-fold
loading dye was added, the reaction mixtures were sub-
jected to 12% polyacrylamide gel electrophoresis in 0.5 
TBE buffer (45mM Tris-base, 45mM boric acid and
1mM EDTA). The gels were dried and exposed to an
imaging plate. The gel images were visualized using an
FLA-7000 imaging analyzer.
The synaptic complex formation assay
DMC1 (4mM) and PSF (0.6mM) were incubated with
a 70-mer oligonucleotide (6mM) in 9ml of reaction
buffer, containing 20mM HEPES–NaOH (pH 7.5),
2mM HEPES–KOH (pH 7.5), 4mM Tris–HCl (pH 8.0),
40mM NaCl, 50mM KCl, 0.045mM EDTA, 3%
glycerol, 0.2mM 2-mercaptoethanol, 1.2mM DTT,
1mM ATP, 5mM MgCl2 and 100mg/ml BSA. After a
5-min incubation at 37 C, 1ml of the supercoiled fX174
dsDNA (30mM) was added, and the reaction was
continued at 37 C for 5min. DNA cleavage was initiated
by the addition of the PstI restriction enzyme (1.13U).
After the PstI treatment, the reaction was stopped by
the addition of 0.2% SDS and 1.5mg/ml proteinase K,
and was further incubated at 37 C for 15min. After
adding 6-fold loading dye, the DNA was separated by
1% agarose gel electrophoresis in 1  TAE buffer at
3.3V/cm for 2h. The bands were visualized by ethidium
bromide staining.
The centrifugation assay for the DNA aggregating activity
Proteins were incubated with fX174 ssDNA (10mM) at
37 C for 5min, in 19ml of reaction buffer, containing
22mM HEPES–NaOH (pH 7.5), 2mM HEPES–KOH
(pH 7.5), 4mM Tris–HCl (pH 8.0), 40mM NaCl,
50mM KCl, 0.045mM EDTA, 0.2mM 2-
mercaptoethanol, 3% glycerol, 5mM MgCl2, 1.2mM
DTT, 1mM ATP and 0.1mg/ml BSA. The reactions
were then initiated by the addition of 1ml of linearized
fX174 dsDNA (10mM), and were further incubated at
37 C for 10min. After this incubation, the samples were
centrifuged for 3min at 20400g at room temperature, and
the upper fractions (15ml) were separated from the bottom
fractions (5ml) of the samples. The DNA was recovered by
a treatment with 0.2% SDS and 1.5mg/ml proteinase K at
37 C for 15min. After adding 6-fold loading dye, the
DNA was separated by 0.8% agarose gel electrophoresis
in 1  TAE buffer at 4V/cm for 2.5h. The bands were
visualized by ethidium bromide staining.
RESULTS
PSF is produced in spermatogonia, spermatocytes and
spermatids
We immunologically stained mouse adult testis cryo-
sections with an anti-PSF monoclonal antibody. As
shown in Figure 1, the PSF antibody stained various
cells, such as spermatogonia, spermatocytes and
spermatids. Sertoli cells were also stained with the PSF
antibody (Figure 1) (43). We tested PSF production
during meiotic stages by analyzing DAZL, STRA8 and
SYCP3, which are produced in spermatogonia/spermato-
cytes, spermatogonia/preleptotene spermatocytes and
spermatocytes, respectively, as differentiation markers
(Supplementary Figure S1). We then conﬁrmed that PSF
was constitutively produced in cells at the stages from
preleptotene spermatocytes to secondary spermatocytes
(Supplementary Figure S1). Therefore, PSF may
function in meiotic events in spermatogenesis.
PSF interacts with DMC1 and RAD51
Previously, we reported that PSF directly binds to
RAD51, which functions as a recombinase in meiotic
and mitotic cells (40). We then tested whether PSF
actually binds to DMC1 and/or RAD51 in mouse testis
cells, by an immunoprecipitation assay with an anti-PSF
antibody. Endogenous mouse DMC1 and/or RAD51
bound to PSF were detected with the anti-human
DMC1 polyclonal antibody, which cross-reacts
with both mouse DMC1 and RAD51. As shown in
Figure 2A, a substantial amount of mouse DMC1 and/
or RAD51 was detected in the PSF-bound fraction,
suggesting that PSF interacts with DMC1 and/or
RAD51 in the mouse testis cell extract. To conﬁrm
whether PSF binds DMC1 and/or RAD51, we performed
the pull-down assay with puriﬁed human proteins. To do
so, PSF was puriﬁed as a His6-tagged protein, and
PSF-DMC1 binding or PSF-RAD51 binding was
detected by the pull-down assay with the Ni-NTA beads.
As shown in Figure 2B and C, puriﬁed human PSF bound
to both human DMC1 and RAD51, suggesting that PSF
binds to both DMC1 and RAD51 in testis cells. However,
in meiotic spermatocytes, PSF did not exhibit clear
co-localization with mouse DMC1 and RAD51 at the
(pre)leptotene and zygotene stages, when many DMC1
and RAD51 foci were formed (Supplementary
Figure S2). Therefore, PSF may bind to DMC1 and
RAD51 before the DMC1/RAD51 foci formation, and
may catalytically function with DMC1/RAD51 during
homologous recombination processes.
PSF stimulates DMC1-mediated homologous pairing
We then tested the effect of PSF on homologous recom-
bination reactions mediated by DMC1. The D-loop for-
mation assay was employed to detect the DMC1-mediated
homologous pairing in vitro. In this assay, the homologous
pairing between a
32P-labeled 50-mer oligonucleotide
and superhelical dsDNA was mediated by DMC1 in an
ATP-dependent manner, and the D-loop structure was
detected as a homologous-pairing product (Figure 3A).
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32P-labeled 50-mer single-
stranded oligonucleotide displaces the identical strand of
the dsDNA, and forms new Watson–Crick base pairs with
its complementary strand.
As shown in Figure 3B (lanes 5–8) and C, we found that
puriﬁed PSF robustly stimulated the DMC1-mediated
D-loop formation in a concentration-dependent manner.
PSF alone weakly promoted D-loop formation
(Figure 3B, lanes 1–4) (40,42). The omission of ATP did
not affect the D-loop formation by PSF alone, but signiﬁ-
cantly inhibited the DMC1-mediated D-loop formation,
regardless of the presence or absence of PSF (Figure 3D).
This suggested that PSF actually stimulated the
ATP-dependent homologous pairing by DMC1. PSF
slightly reduced the ATP hydrolyzing activities of
DMC1 in the presence of the 49-mer single-stranded
oligonucleotide, but the difference was not signiﬁcant
(Supplementary Figure S3). Since ATP hydrolysis
promotes DMC1 dissociation from ssDNA, PSF does
not seem to stabilize the DMC1–ssDNA complex by
inhibiting ATP hydrolysis and thus reducing its dissoci-
ation from ssDNA. Consistently, PSF did not alter the
D-loop formation-dissociation kinetics of DMC1,
although the yield of D-loops formed by DMC1 was
signiﬁcantly increased in the presence of PSF
(Supplementary Figure S4).
We also performed the homologous-pairing assay with
a 63-mer single-stranded oligonucleotide and a 32-mer
duplex oligonucleotide, in which the displaced strand of
the duplex was labeled by
32P (Figure 3E). Consistent with
the results of the D-loop assay, PSF signiﬁcantly enhanced
the DMC1-mediated homologous pairing with this
combination of DNA substrates (Figure 3F). Therefore,
we conclude that PSF may function as a bona ﬁde activa-
tor of DMC1 during meiotic homologous recombination.
PSF stimulates dsDNA capture by the DMC1–ssDNA
complex during homologous pairing
We next performed a dsDNA capture assay with the
DMC1–ssDNA complex. During homologous pairing,
DMC1 forms a ternary complex (synaptic complex),
containing ssDNA and dsDNA, and homologous
pairing between ssDNA and dsDNA is mediated within
this synaptic complex. The synaptic complex formation
can be tested by the dsDNA capture assay. DMC1 was
incubated with magnetic streptavidin beads conjugated
with an 83-mer poly dT ssDNA, and the DMC1–ssDNA
complex was formed. The DMC1–ssDNA complexes were
then incubated with the
32P-labeled dsDNA, and the
dsDNA incorporated into the synaptic complex was
detected by the pull-down assay (Figure 4A) (26). Under
the experimental conditions used in this assay, trace
amounts of the dsDNA captured by the DMC1–ssDNA
complex or the PSF–ssDNA complex were detected
(Figure 4B, lanes 2 and 3). In contrast, signiﬁcant
amounts of dsDNA were incorporated into the synaptic
complex, when PSF coexisted with DMC1 in the presence
of ssDNA (Figure 4B, lane 4). Interestingly, PSF did
not enhance the stability of the DMC1–ssDNA and
RAD51–ssDNA complexes, as revealed by the ssDNA
protection assay with exonuclease I (Figure 4C and D).
Therefore, PSF may mainly function in the dsDNA
capture step during the DMC1-mediated homologous
pairing.
We next performed the restriction enzyme protection
assay. In this assay, a dsDNA is protected from cleavage
Figure 1. Double immunostaining of mouse testis sections (3months) for PSF (green) and SYCP3 (red) counterstained with a Hoechst dye (blue).
Upper and lower panels are low and high magniﬁcation, respectively. Scale bars, 10mm.
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formed with the ssDNA containing the homologous
sequence of the PstI site by DMC1 and PSF (Figure 4E)
(21,54). We found that PSF signiﬁcantly enhanced the
DMC1-mediated synaptic complex formation at the hom-
ologous region of the dsDNA (Figure 4F, lanes 2–5, and
G). In contrast, the PstI digestion was not prevented when
an ssDNA containing a heterologous sequence was used
as the substrate for the DMC1-mediated synaptic complex
formation (Figure 4F, lanes 6–9, and G). These results
suggested that, although the synaptic complex formation
occurs in a homology-independent manner, the synaptic
complex may be predominantly formed or stabilized on
the homologous dsDNA region.
PSF forms DNA aggregates
The bacterial recombinase, RecA, aggregates ssDNA and
dsDNA, thus providing DNA ﬁelds in which the local
concentrations of ssDNA and dsDNA are increased to
levels suitable for homologous pairing (55,56). In the
present study, we found that PSF possessed DNA aggre-
gation activity. ssDNA and dsDNA were incubated with
DMC1 and/or PSF, and the samples were brieﬂy
centrifuged at room temperature. The DNA aggregates
formed by the proteins were detected in the bottom
fraction of the samples (Figure 5A). As shown in
Figure 5B, in the presence of ssDNA and dsDNA,
DMC1 formed aggregates only with ssDNA (lanes 2 and
6). On the other hand, PSF formed aggregates with both
ssDNA and dsDNA, and no DNA was observed in the
supernatant (upper) fraction (Figure 5B, lanes 3 and 7).
The same result was obtained when PSF and DMC1
coexisted (Figure 5B, lanes 4 and 8). Therefore, we
concluded that PSF stimulated dsDNA capture by
the DMC1–ssDNA complex, by increasing the local
ssDNA and dsDNA concentrations by its aggregation
activity.
We compared the DNA aggregation activity of PSF
with the HOP2–MND1 complex, which is known to be
a bona ﬁde auxiliary factor for DMC1 (17–21). Unlike
PSF, HOP2–MND1 alone did not form aggregates with
ssDNA and dsDNA (Figure 5C, lanes 3 and 7). However,
both ssDNA and dsDNA were readily incorporated into
aggregates in the presence of DMC1 (Figure 5C, lanes
4 and 8). Although the intrinsic DNA aggregation
activity was different between PSF and HOP2–MND1,
both auxiliary factors have some similar functions in the
presence of DMC1.
DISCUSSION
In the present study, we found that human PSF robustly
stimulated DMC1-mediated homologous pairing. PSF
enhanced the dsDNA capture by the DMC1–ssDNA
complex, probably through ssDNA and dsDNA aggrega-
tion (Figure 6). DMC1 alone also exhibited the DNA
aggregation activity, but only for ssDNA. Therefore,
PSF may be required for efﬁcient dsDNA capture by
DMC1, through its aggregation activity for ssDNA and
dsDNA. PSF reportedly has weak homologous pairing
activity (40,42). This may occur by the spontaneous
pairing between ssDNA and dsDNA within the
aggregated DNA state produced by PSF.
So far, the Hop2-Mnd1 complexes (17–21), the yeast
Swi5–Sfr1 complex (22), human RAD54B (14,23,24) and
RAD51AP1 (25) have been reported to stimulate homolo-
gous pairing mediated by Dmc1. The Hop2-Mnd1
complex is known to enhance Dmc1-mediated homolo-
gous pairing (17–20) in two ways, by stabilizing the
Dmc1–ssDNA complex and facilitating the dsDNA
capture by the Dmc1–ssDNA complex (21). The HOP2–
MND1 complex also reportedly exhibits dsDNA
condensing activity (57). Interestingly, we found that the
DNA aggregation activity of HOP2–MND1 alone is
not apparently signiﬁcant, but HOP2–MND1 promotes
Figure 2. PSF binds to DMC1. (A) The PSF-DMC1/RAD51
interaction was detected in an extract prepared from mouse testis by
the pull-down assay with the anti-PSF antibody-conjugated beads.
Immunoprecipitates with the anti-PSF antibody were analyzed using
an anti-human DMC1 antibody. Lane 1 represents the input (3%).
Lane 2 indicates the experiment with the anti-PSF antibody. Lane 3
indicates a negative control experiment with mouse normal IgG. Lanes
4 and 5 show puriﬁed protein controls of human DMC1 and RAD51,
respectively. (B) The pull-down assay with Ni–NTA beads. Lane 1
represents molecular mass markers. Lanes 2, 3 and 6 show puriﬁed
protein controls of PSF, DMC1 and RAD51, respectively. Lanes 4
and 7 indicate negative control experiments with DMC1 and RAD51,
respectively, in the absence of His6-tagged PSF. Lanes 5 and 8 indicate
experiments with DMC1 and RAD51, respectively, in the presence of
His6-tagged PSF. The proteins bound to His6-tagged PSF were pulled
down by the Ni–NTA agarose beads. The samples were fractionated by
15% SDS–PAGE, and the protein bands were visualized by Coomassie
Brilliant Blue staining. (C) Graphic representation of the Ni–NTA
agarose bead pull-down assay shown in panel B. The DMC1 and
RAD51 band intensities were quantitated, and the average values of
three independent experiments are shown with the SD values.
3036 Nucleic Acids Research, 2012,Vol.40, No. 7DNA aggregation with DMC1. Similarly, PSF robustly
enhanced the dsDNA capture by the DMC1–ssDNA
complex, through its DNA aggregation activity.
However, PSF did not stabilize the DMC1–ssDNA
complex, unlike the HOP2–MND1 complex.
RAD51AP1 was identiﬁed as a RAD51 associating
protein, and enhanced the RAD51-mediated homologous
pairing (27,28,58). RAD51AP1 also stimulates dsDNA
capture by the DMC1–ssDNA complex (25), but no
DNA aggregation activity has been reported. Human
RAD54B is an ortholog of the yeast meiotic Rad54
paralog, Tid1/Rdh54 (59,60) and its interactions with
DMC1 stimulate the DMC1-mediated recombination
reaction, probably by stabilizing the DMC1–ssDNA
complex (23,24). Similarly, the yeast Swi5–Sfr1 complex
directly binds to Dmc1, and stabilizes the active Dmc1–
ssDNA complex (22). Therefore, RAD54B and the
Swi5–Sfr1 complex may primarily function in the
Dmc1–ssDNA complex formation step, unlike PSF.
Previously, we reported that PSF modulates
RAD51-mediated homologous pairing (40). PSF only
stimulates the RAD51-mediated D-loop formation by
about 3-fold under conditions with lower amounts of
RAD51, and is rather inhibitory with higher amounts of
RAD51 (40). However, in the present study, we found that
PSF enhanced the yield of D-loops by DMC1, in the
presence of both lower and higher amounts of DMC1
(data not shown). With higher PSF or DMC1 concentra-
tions, PSF robustly stimulated DMC1-mediated homolo-
gous pairing by about 18-fold. This indicates that DMC1
favors the ssDNA and dsDNA aggregated situation for
homologous pairing (Figure 6). In contrast, RAD51 may
not properly function in the highly aggregated DNA
situation produced by PSF. This difference in the PSF
Figure 3. Human PSF stimulates DMC1-mediated homologous pairing. (A) A schematic representation of the D-loop formation assay. Asterisks
indicate the
32P-labeled end of the 50-mer ssDNA. (B) The D-loop formation assay. The reactions were conducted without DMC1 (lanes 1–4) or with
4mM DMC1 (lanes 5–8) in the presence of increasing amounts of PSF. The PSF concentrations were 0mM (lanes 1 and 5), 0.3mM (lanes 2 and 6),
0.6mM (lanes 3 and 7) and 1.2mM (lanes 4 and 8). (C) Graphic representation of the experiments shown in panel B. The average values of three
independent experiments are shown with the SD values. Closed and open circles represent the experiments without and with DMC1, respectively. (D)
The D-loop formation assay without ATP. The reactions were conducted without DMC1 (lanes 1–3 and 8) or with 4mM DMC1 (lanes 4–7 and 9) in
the presence of increasing amounts of PSF. The PSF concentrations were 0mM (lanes 1, 4 and 7), 0.6mM (lanes 2 and 5) and 1.2mM (lanes 3, 6, 8
and 9). Lanes 1–6 represent experiments without ATP, and lanes 7–9 represent control experiments with ATP. (E) A schematic representation of the
homologous-pairing assay with oligonucleotides. Asterisks indicate the
32P-labeled end of the 32-mer strand, which is complementary to the ssDNA
63-mer. The dsDNA 32-mers were prepared by annealing the
32P-labeled 32-mer strand with the complementary 32-mer. (F) The ssDNA 63-mer
(15mM) was incubated with DMC1 (4mM) in the presence of the indicated amounts of PSF. The reactions were initiated by adding dsDNA (1.5mM).
Lane 1 indicates a negative control experiment without proteins. Lane 7 indicates a negative control experiment without DMC1, in the presence of
PSF (1.2mM). The PSF concentrations were 0mM (lane 2), 0.3mM (lane 3), 0.6mM (lane 4), 0.9mM (lane 5) and 1.2mM (lane 6).
Nucleic Acids Research,2012, Vol.40, No. 7 3037action between DMC1 and RAD51 may be due to the
distinctive aspects of their intrinsic DNA binding and/or
homologous-pairing activities.
In the present study, we have reported that PSF is a
novel DMC1 activating protein. It remains to be clariﬁed
how PSF shares the DMC1-stimulating activity with the
previously identiﬁed HOP2–MND1 complex, RAD54B
and RAD51AP1 in mammals. They may function in
distinct chromosomal locations and/or in genomic DNA
regions with speciﬁc sequence characteristics. These
DMC1 activators may function in different steps, such
as in DMC1–ssDNA complex formation, synaptic
Figure 4. PSF stimulates dsDNA capture by the DMC1–ssDNA complex. (A) Schematic representation of the dsDNA capturing assay. Asterisks
indicate the
32P-labeled ends of the dsDNA. (B) The reaction was conducted with DMC1 (4mM) and/or PSF (0.6mM), and
32P-labeled dsDNA
49-mer (1.5mM) in the presence of the 83-mer poly dT ssDNA conjugated to the beads. The dsDNA captured by the DMC1–ssDNA complex was
detected. Lane 1 indicates a negative control reaction without the proteins. Lanes 2–4 represent the experiments with DMC1 alone, PSF alone, and
both DMC1 and PSF, respectively. Portions including 80% of the dsDNA recovered in the ssDNA bound fraction were analyzed by native PAGE
(upper panel), and 10% portions of the dsDNA samples remaining in the ssDNA unbound fraction were analyzed by native PAGE (lower panel).
(C) The ssDNA protection assay with DMC1. The DMC1–ssDNA complexes were treated with exonuclease I in the presence or absence of PSF.
The resulting ssDNAs were analyzed by native PAGE. Lane 1 indicates a negative control experiment without proteins and exonuclease I. Lanes 3, 6,
9 and 12 indicate experiments with 0.3mM PSF, and lanes 4, 7, 10 and 13 indicate experiments with 0.6mM PSF. Lanes 2, 5, 8 and 11 indicate
experiments without PSF. The DMC1 concentrations were 0mM (lanes 2–4), 0.5mM (lanes 5–7), 1mM (lanes 8–10) and 2mM (lanes 11–13). (D) The
ssDNA protection assay with RAD51. The reaction was conducted by the same method as in panel C, except RAD51 was used instead of DMC1.
(E) Schematic representation of the synaptic complex formation assay. (F) The synaptic complex formation reaction was conducted with DMC1
(4mM) and/or PSF (0.6mM), in the presence of the 70-mer ssDNA and superhelical dsDNA. Lane 1 indicates a negative control experiment without
proteins and PstI restriction enzyme. Lanes 2 and 6 represent the experiments without proteins. Lanes 2–5 and 6–9 indicate experiments with the
homologous ssDNA and heterologous ssDNA, respectively. Lanes 3 and 7 indicate the experiments with DMC1 alone. Lanes 4 and 8 indicate the
experiments with PSF alone. Lanes 5 and 9 indicate the experiments with both DMC1 and PSF. NC and SC represent nicked circular and
superhelical dsDNA molecules. (G) Graphic representation of the synaptic complex formation assay shown in panel F. The band intensities of
the protected DNAs were quantitated, and the average values of three independent experiments are shown with the SD values.
3038 Nucleic Acids Research, 2012,Vol.40, No. 7complex formation and heteroduplex formation. Further
studies will be required to clarify this issue.
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